By Notice dated July 13, 2001, and published in the Federal Register on July 23, 2001, (66 FR 38323), Lonza Riverside, 900 River Road, Conshohocken, Pennsylvania 19428, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed below:
|Gamma hydroxybutyric acid (2010)||I|
The firm plans to manufacture phenylacetone to produce amphetamine. They plan to manufacture amphetamine and gamma hydroxybutyric acid in bulk for distribution to its customers.
No comments or objections were received. DEA has considered the factors in Title 21, United States code, section 823(a) and determined that the registration of Lonza Riverside to manufacture the listed controlled substances is consistent with the public interest at this time. DEA has investigated Lonza Riverside on a regular basis to ensure that the company's continued registration is consistent with the public interest. These investigations have included inspection and testing of the company's physical security systems, audits of the company's records, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR § 0.100 and 0.104, the Deputy Assistant Administrator, Office of Diversion Control, hereby orders that the application submitted by the above firm for registration as a bulk manufacturer of the basic classes of controlled substances listed above is granted.Start Signature
Dated: March 27, 2002.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 02-8673 Filed 4-9-02; 8:45 am]
BILLING CODE 4410-09-M